163 related articles for article (PubMed ID: 7595210)
1. A naturally occurring soluble isoform of murine Fas generated by alternative splicing.
Hughes DP; Crispe IN
J Exp Med; 1995 Nov; 182(5):1395-401. PubMed ID: 7595210
[TBL] [Abstract][Full Text] [Related]
2. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
Liu C; Cheng J; Mountz JD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):957-63. PubMed ID: 7575433
[TBL] [Abstract][Full Text] [Related]
4. A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain.
Nakajima T; Ichii S; Furuyama J; Tamaoki T; Hashimoto T
Life Sci; 1996; 58(9):761-8. PubMed ID: 8632723
[TBL] [Abstract][Full Text] [Related]
5. Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA.
Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Biochem Biophys Res Commun; 2018 Nov; 506(3):703-708. PubMed ID: 30376989
[TBL] [Abstract][Full Text] [Related]
6. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
7. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of the cDNA of a murine soluble Fas.
Hu Z; Zou P; Li A; Xiao J; Zhong Z; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):186-9, 196. PubMed ID: 12658799
[TBL] [Abstract][Full Text] [Related]
9. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Kasahara Y; Wada T; Niida Y; Yachie A; Seki H; Ishida Y; Sakai T; Koizumi F; Koizumi S; Miyawaki T; Taniguchi N
Int Immunol; 1998 Feb; 10(2):195-202. PubMed ID: 9533447
[TBL] [Abstract][Full Text] [Related]
10. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.
Cheng J; Zhou T; Liu C; Shapiro JP; Brauer MJ; Kiefer MC; Barr PJ; Mountz JD
Science; 1994 Mar; 263(5154):1759-62. PubMed ID: 7510905
[TBL] [Abstract][Full Text] [Related]
11. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
Puppo F; Contini P; Ghio M; Indiveri F
ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis.
Villamizar O; Chambers CB; Riberdy JM; Persons DA; Wilber A
Oncotarget; 2016 Mar; 7(12):13810-26. PubMed ID: 26885613
[TBL] [Abstract][Full Text] [Related]
13. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
Siegel RM; Frederiksen JK; Zacharias DA; Chan FK; Johnson M; Lynch D; Tsien RY; Lenardo MJ
Science; 2000 Jun; 288(5475):2354-7. PubMed ID: 10875918
[TBL] [Abstract][Full Text] [Related]
14. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.
Suda T; Tanaka M; Miwa K; Nagata S
J Immunol; 1996 Nov; 157(9):3918-24. PubMed ID: 8892623
[TBL] [Abstract][Full Text] [Related]
16. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
17. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
18. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.
Papoff G; Cascino I; Eramo A; Starace G; Lynch DH; Ruberti G
J Immunol; 1996 Jun; 156(12):4622-30. PubMed ID: 8648105
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells.
Watanabe D; Suda T; Nagata S
Int Immunol; 1995 Dec; 7(12):1949-56. PubMed ID: 8746564
[TBL] [Abstract][Full Text] [Related]
20. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
Yang Y; Merćep M; Ware CF; Ashwell JD
J Exp Med; 1995 May; 181(5):1673-82. PubMed ID: 7536793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
